Retrospective Cohort Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Apr 28, 2017; 23(16): 2957-2963
Published online Apr 28, 2017. doi: 10.3748/wjg.v23.i16.2957
Table 2 Characteristics after treatment (3 mo)
CharacteristicObservation groupControlgroupP value
Leukocytes (× 109/L)5.60 ± 1.035.52 ± 0.980.748
Neutrophils (× 109/L)4.13 ± 0.684.20 ± 0.750.652
Hemoglobin (g/L)116.57 ± 12.81111.22 ± 13.390.087
Platelets (× 109/L)107.82 ± 17.45108.37 ± 12.130.521
Blood urea nitrogen (mmol/L)5.95 ± 1.527.57 ± 1.760.000
Sodium (mmol/L)126.15 ± 8.74125.64 ± 10.320.828
Albumin (g/L)34.86 ± 4.3632.79 ± 4.390.048
Total bilirubin (μmol/L)56.11 ± 19.1367.49 ± 19.700.016
Alanine aminotransferase (U/L)63.79 ± 17.1677.81 ± 16.750.001
Aspartate aminotransferase (U/L)83.93 ± 19.9292.48 ± 20.240.076
Gamma glutamyl transpeptidase (U/L)78.29 ± 15.1486.04 ± 14.960.032
Prothrombin time (s)17.46 ± 1.8518.59 ± 2.260.038
International normalized ratio1.59 ± 0.171.69 ± 0.210.038
Maddrey’s discriminant function19.22 ± 8.8425.07 ± 10.590.014
Child-Turcotte-Pugh8.52 ± 1.509.89 ± 1.970.002